Walleye Trading’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.33M | Sell |
10,400
-13,800
| -57% | -$3.44M | ﹤0.01% | 1612 |
|
|
2025
Q4 | $5.83M | Buy |
24,200
+700
| +3% | +$179K | 0.01% | 1201 |
|
|
2025
Q3 | $6.43M | Sell |
23,500
-11,900
| -34% | -$3.25M | 0.01% | 1119 |
|
|
2025
Q2 | $9.13M | Buy |
35,400
+14,800
| +72% | +$3.53M | 0.02% | 868 |
|
|
2025
Q1 | $4.61M | Buy |
20,600
+12,800
| +164% | +$2.99M | 0.01% | 1148 |
|
|
2024
Q4 | $1.78M | Sell |
7,800
-63,700
| -89% | -$15.3M | ﹤0.01% | 1762 |
|
|
2024
Q3 | $17.5M | Buy |
71,500
+21,800
| +44% | +$4.87M | 0.04% | 515 |
|
|
2024
Q2 | $9.51M | Buy |
49,700
+23,000
| +86% | +$4.67M | 0.02% | 705 |
|
|
2024
Q1 | $5.29M | Buy |
26,700
+12,900
| +93% | +$2.36M | 0.01% | 1086 |
|
|
2023
Q4 | $2.37M | Buy |
13,800
+10,900
| +376% | +$1.67M | 0.01% | 1797 |
|
|
2023
Q3 | $429K | Sell |
2,900
-3,300
| -53% | -$597K | ﹤0.01% | 3074 |
|
|
2023
Q2 | $1.35M | Buy |
6,200
+900
| +17% | +$201K | ﹤0.01% | 1932 |
|
|
2023
Q1 | $1.16M | Buy |
+5,300
| New | +$1.15M | ﹤0.01% | 2083 |
|
|
2022
Q4 | – | Sell |
-900
| Closed | -$196K | – | 5344 |
|
|
2022
Q3 | $196K | Sell |
900
-13,300
| -94% | -$3.03M | ﹤0.01% | 3688 |
|
|
2022
Q2 | $2.98M | Buy |
+14,200
| New | +$3.02M | 0.01% | 1365 |
|
|
2022
Q1 | – | Sell |
-100
| Closed | -$26K | – | 5839 |
|
|
2021
Q4 | $26K | Sell |
100
-1,200
| -92% | -$311K | ﹤0.01% | 4854 |
|
|
2021
Q3 | $343K | Buy |
+1,300
| New | +$355K | ﹤0.01% | 3329 |
|
|
2021
Q2 | – | Sell |
-4,100
| Closed | -$795K | – | 5485 |
|
|
2021
Q1 | $795K | Sell |
4,100
-6,300
| -61% | -$1.26M | ﹤0.01% | 2147 |
|
|
2020
Q4 | $2.21M | Sell |
10,400
-200
| -2% | -$39.9K | 0.01% | 1318 |
|
|
2020
Q3 | $1.82M | Buy |
10,600
+5,500
| +108% | +$1.02M | 0.01% | 1195 |
|
|
2020
Q2 | $979K | Buy |
5,100
+1,300
| +34% | +$213K | 0.01% | 1683 |
|
|
2020
Q1 | $560K | Buy |
3,800
+100
| +3% | +$15.9K | ﹤0.01% | 1789 |
|
|
2019
Q4 | $573K | Sell |
3,700
-4,700
| -56% | -$677K | ﹤0.01% | 2293 |
|
|
2019
Q3 | $1.14M | Sell |
8,400
-21,400
| -72% | -$2.8M | 0.01% | 1500 |
|
|
2019
Q2 | $3.64M | Buy |
29,800
+22,300
| +297% | +$2.47M | 0.03% | 643 |
|
|
2019
Q1 | $780K | Buy |
7,500
+7,200
| +2,400% | +$743K | 0.01% | 1890 |
|
|
2018
Q4 | $34K | Sell |
300
-21,200
| -99% | -$2.27M | ﹤0.01% | 4243 |
|
|
2018
Q3 | $2.48M | Buy |
21,500
+12,500
| +139% | +$1.37M | 0.01% | 1128 |
|
|
2018
Q2 | $932K | Buy |
+9,000
| New | +$911K | 0.01% | 2183 |
|
|
2017
Q4 | – | Sell |
-1,000
| Closed | -$77 | – | 4593 |
|
|
2017
Q3 | $77 | Sell |
1,000
-10,700
| -91% | -$819K | ﹤0.01% | 3697 |
|
|
2017
Q2 | $911 | Sell |
11,700
-22,800
| -66% | -$1.63M | 0.01% | 1858 |
|
|
2017
Q1 | $2.48K | Buy |
34,500
+4,500
| +15% | +$311K | 0.02% | 927 |
|
|
2016
Q4 | $1.86M | Buy |
30,000
+10,300
| +52% | +$631K | 0.01% | 1018 |
|
|
2016
Q3 | $1.28M | Buy |
19,700
+18,700
| +1,870% | +$1.24M | 0.01% | 1337 |
|
|
2016
Q2 | $63K | Sell |
1,000
-1,100
| -52% | -$64.8K | ﹤0.01% | 3834 |
|
|
2016
Q1 | $122K | Buy |
+2,100
| New | +$119K | ﹤0.01% | 3183 |
|
|
2014
Q3 | – | Sell |
-100
| Closed | -$5 | – | 4319 |
|
|
2014
Q2 | $5 | Buy |
+100
| New | +$4.96K | ﹤0.01% | 3507 |
|
|
2013
Q4 | – | Sell |
-1,700
| Closed | -$89K | – | 3775 |
|
|
2013
Q3 | $89K | Sell |
1,700
-400
| -19% | -$19.4K | ﹤0.01% | 2030 |
|
|
2013
Q2 | $95K | Buy |
+2,100
| New | +$99.6K | ﹤0.01% | 2033 |
|
Other funds holding RMD
VCM
VPM
DAM
Walleye Trading's RMD Position: Q1 2026 in Review
Walleye Trading reduced its ResMed (RMD) stake by 66% in Q1 2026, selling an estimated $654K and leaving 1,335 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #2883.
Walleye Trading first reported a position in RMD in Q2 2013 and has held it in 29 quarters since. The position peaked at $2.95M in Q1 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Walleye Trading held 1,335 shares of ResMed worth $300K as of Q1 2026.
- Walleye Trading sold 2,623 ResMed shares in Q1 2026, an estimated $654K.
- ResMed made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2883 holding.
- Walleye Trading first reported a position in ResMed in Q2 2013 and has held it in 29 quarters since.
- Walleye Trading's ResMed position peaked at $2.95M in Q1 2024.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.